SCHEMBL25344129

SCHEMBL25344129

Cc1nc(O)c2cnn(-c3ccc(F)cc3F)c2n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 4/20 0.49
CYP1A2 P05177 3/20 0.49
GLA P06280 1/20 0.41
MAPK14 Q16539 4/20 0.38
SCN9A Q15858 3/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
TSHR P16473 3/20 0.38
POLB P06746 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 2/20 0.38
ALDH1A1 P00352 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
CRHR1 P34998 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25977715 0.86 CYP17A1 (0.51) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL25345230 0.85 SLC2A1 (0.43) CYP17A1CYP1A2SMN1; SMN2TSHRPOLB
SCHEMBL30568679 0.85 SLC2A1 (0.43) CYP17A1CYP1A2SMN1; SMN2TSHRPOLB
SCHEMBL25344584 0.84 CYP17A1 (0.49) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL5009869 0.84 CYP17A1 (0.51) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL30568732 0.84 CYP17A1 (0.49) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL25343453 0.82 CYP17A1 (0.42) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL30568412 0.82 CYP17A1 (0.42) CYP17A1CYP1A2GLAMAPK14SCN9A
SCHEMBL25344027 0.82 CYP17A1 (0.43) CYP17A1CYP1A2GLAMAPK14SMN1; SMN2
SCHEMBL30568695 0.82 CYP17A1 (0.43) CYP17A1CYP1A2GLAMAPK14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472739-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-12-11 EP disclosed
WO-2023148129-A1 IMIDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-08-10 WO disclosed